Cognitive dysfunction in patients with multiple sclerosis treated with different types of interferon beta: A randomized clinical trial

Conclusions: Different types of DMTs may improve some aspects of cognitive function in patients with MS. Treatment with Avonex and Rebif (Interferon beta-1a preparations) were more helpful in resolving the cognitive impairments in MS patients compared to Betaferon (Interferon beta-1b) as investigated in this study.

Source: Journal of the Neurological Sciences - May 19, 2014 Category: Neurology Authors: Naghmeh Mokhber, Amir Azarpazhooh, Elias Orouji, Stephen M. Rao, Bita Khorram, Mohammad Ali Sahraian, Mohsen Foroghipoor, Morteza Modares Gharavi, Sorayya Kakhi, Karim Nikkhah, Mahmoud Reza Azarpazhooh Tags: Original Articles Source Type: research